Repositioning of the global epicentre of non-optimal cholesterol
High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct...
Published in: | Nature |
---|---|
Main Authors: | , , , |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.publisso.de/resource/frl:6426178 https://doi.org/10.1038/s41586-020-2338-1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332422/ https://www.nature.com/articles/s41586-020-2338-1#Sec18 |
id |
ftleibnizopen:oai:oai.leibnizopen.de:c-MksIYBdbrxVwz6T8ew |
---|---|
record_format |
openpolar |
spelling |
ftleibnizopen:oai:oai.leibnizopen.de:c-MksIYBdbrxVwz6T8ew 2023-05-15T16:30:18+02:00 Repositioning of the global epicentre of non-optimal cholesterol NCD Risk Factor Collaboration (NCD-RisC) Ahrens, Wolfgang Pigeot, Iris Pohlabeln, Hermann 2020 https://repository.publisso.de/resource/frl:6426178 https://doi.org/10.1038/s41586-020-2338-1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332422/ https://www.nature.com/articles/s41586-020-2338-1#Sec18 eng eng http://creativecommons.org/licenses/by/4.0/ CC-BY Nature, 582(2):73-77 Cardiovascular diseases Risk factors 2020 ftleibnizopen https://doi.org/10.1038/s41586-020-2338-1 2023-03-06T00:33:26Z High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk—changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million–4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment ... Other/Unknown Material Greenland Iceland LeibnizOpen (The Leibniz Association) Greenland Pacific Norway Nature 582 7810 73 77 |
institution |
Open Polar |
collection |
LeibnizOpen (The Leibniz Association) |
op_collection_id |
ftleibnizopen |
language |
English |
topic |
Cardiovascular diseases Risk factors |
spellingShingle |
Cardiovascular diseases Risk factors NCD Risk Factor Collaboration (NCD-RisC) Ahrens, Wolfgang Pigeot, Iris Pohlabeln, Hermann Repositioning of the global epicentre of non-optimal cholesterol |
topic_facet |
Cardiovascular diseases Risk factors |
description |
High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk—changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million–4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment ... |
author |
NCD Risk Factor Collaboration (NCD-RisC) Ahrens, Wolfgang Pigeot, Iris Pohlabeln, Hermann |
author_facet |
NCD Risk Factor Collaboration (NCD-RisC) Ahrens, Wolfgang Pigeot, Iris Pohlabeln, Hermann |
author_sort |
NCD Risk Factor Collaboration (NCD-RisC) |
title |
Repositioning of the global epicentre of non-optimal cholesterol |
title_short |
Repositioning of the global epicentre of non-optimal cholesterol |
title_full |
Repositioning of the global epicentre of non-optimal cholesterol |
title_fullStr |
Repositioning of the global epicentre of non-optimal cholesterol |
title_full_unstemmed |
Repositioning of the global epicentre of non-optimal cholesterol |
title_sort |
repositioning of the global epicentre of non-optimal cholesterol |
publishDate |
2020 |
url |
https://repository.publisso.de/resource/frl:6426178 https://doi.org/10.1038/s41586-020-2338-1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332422/ https://www.nature.com/articles/s41586-020-2338-1#Sec18 |
geographic |
Greenland Pacific Norway |
geographic_facet |
Greenland Pacific Norway |
genre |
Greenland Iceland |
genre_facet |
Greenland Iceland |
op_source |
Nature, 582(2):73-77 |
op_rights |
http://creativecommons.org/licenses/by/4.0/ |
op_rightsnorm |
CC-BY |
op_doi |
https://doi.org/10.1038/s41586-020-2338-1 |
container_title |
Nature |
container_volume |
582 |
container_issue |
7810 |
container_start_page |
73 |
op_container_end_page |
77 |
_version_ |
1766020025970327552 |